Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?

J Nucl Cardiol. 2021 Aug;28(4):1757-1759. doi: 10.1007/s12350-019-01964-w. Epub 2019 Dec 2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Fluorodeoxyglucose F18*
  • Heart Diseases / complications
  • Heart Diseases / diagnostic imaging*
  • Humans
  • Myocardial Perfusion Imaging*
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Prognosis
  • Radiopharmaceuticals*
  • Sarcoidosis / complications
  • Sarcoidosis / diagnostic imaging*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18